Immunotherapy (Pembrolizumab) Clinical Trials
3 recruitingDrug
Phase 23Phase 32
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Unresectable MelanomaCutaneous MelanomaMelanoma (Skin Cancer)+1 more
Linnaeus Therapeutics, Inc.135 enrolled9 locationsNCT06624644
Recruiting
Phase 2Phase 3
Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
Locally Advanced Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital120 enrolled1 locationNCT06907602
Recruiting
Phase 2
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
CNAO National Center of Oncological Hadrontherapy27 enrolled4 locationsNCT05229614